Effective treatment of refractory pulmonary hemorrhage with monoclonal anti-CD20 antibody (Rituximab)

Respiration

Volumn 78, Issue 1, 2009, Pages 106-109

  Pinto, Luis Fernando ^a   Candia, Liliana ^c   Garcia, Patricia ^d   Marín, Juan Ignacio ^b   Pachón, Ines ^b   Espinoza, Luis R ^c   Marquez, Javier ^a  

^a HOSPITAL PABLO TOBÓN URIBE   (Colombia)

^b Hospital Pablo Tobón Uribe   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Clinica Universitaria Bolivariana   (Colombia)

Author keywords

Lupus; Pulmonary hemorrhage; Rituximab; Vasculitis

Indexed keywords

CHLOROQUINE; CYCLOPHOSPHAMIDE; HYDROCORTISONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; HUMAN; LUNG HEMORRHAGE; LUPUS ERYTHEMATOSUS NEPHRITIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HEMOPTYSIS; HUMANS; LUPUS NEPHRITIS; YOUNG ADULT;

EID: 67749089434     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000156965     Document Type: Article

References (17)

1. Piastraa M, Ruggiero A, Langer A, et al: Pulmonary hemorrhage complicating a typical hemolytic-uremic syndrome. Respiration 2004; 71: 537-541.
2. Rutherford RM, O'Keeffe D, Gilmartin JJ: An unusual case of non-specific interstitial pneumonitis. Respiration 2004; 71: 202-205.
3. Hoshi K, Matsuda M, Ishikawa M, et al: Successful treatment of fulminant pulmonary hemorrhage associated with systemic lupus erythematosus. Clin Rheumatol 2004; 23: 252-255.
4. Erickson RW, Franklin WA, Emlen W, et al: Treatment of hemorrhagic lupus pneumoni-tis with plasmapheresis. Semin Arthritis Rheum 1994; 24:114-123.
5. Silverman GJ: Anti-CD20 therapy in systemic lupus erythematosus: a step closer to the clinic. Arthritis Rheum 2005; 52:371-377.
6. Armstrong DJ, Wright SA, Finch MB, et al: Active systemic lupus erythematosus successfully treated with rituximab and oral steroids. Clin Exp R heumatol 2004; 22: 787- 788.
7. Cragg MS, Walshe CA, Ivanov AO, et al: The biology of CD20 and its potential as a target for mAb therapy. Curr Dir Autoimmun 2005; 8: 14 0 -174.
8. Wu CY, Chiou YH, Chiu PC, Hsieh KS: Severe pulmonary hemorrhage as the initial manifestation in systemic lupus erythematosus with active nephritis. Lupus 2001; 10: 879-882.
9. Lee JG, Joo KW, Chung WK, Jung YC, Zheung SH, Yoon HJ, et al: Diffuse alveolar hemorrhage in lupus nephritis. Clin Nephrol 2001; 55:282-288.
10. Santos-Ocampo AS, Mandell BF, Fessler BJ: Alveolar hemorrhage in systemic lupus ery-thematosus: presentation and management. Chest 2000; 118:1083-1090.
11. Liu MF, Lee JH, Weng TH, Lee YY: Clinical experience of 13 cases with severe pulmonary hemorrhage in systemic lupus erythe-matosus with active nephritis. Scand J Rheu-matol 1998; 27: 291-295.
12. Barile JA, Jara LJ, Medina-Rodríguez F, et al: Pulmonary hemorrhage in systemic lupus erythematosus. Lupus 1997; 6:445-448.
13. Looney RJ, Anolik J, Sanz I: Treatment of SLE with anti-CD20 monoclonal antibody. Curr Dir Autoimmun 2005; 8:193-195.
14. Walsh M, Jayne D: Rituximab in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis and systemic lupus ery-thematosus: past, present and future. Kidney Int 2007; 72: 676 - 682.
15. Cacoub P, Saadoun D: Hepatitis C virus infection induced vasculitis. Clin Rev Allergy Immunol 2008;35:30-39.
16. Heresi GA, Farver CF, Stoller JK: Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab. Case report and review of the literature. Respiration 2008; 76:449-453.
17. Camus P, Fanton A, Bonniaud P, et al: Interstitial lung disease induced by drugs and radiation. Respiration 2004; 71: 301-326.